Quote | Alvotech (NASDAQ:ALVO)
Last: | $13.54 |
---|---|
Change Percent: | -1.12% |
Open: | $13.55 |
Close: | $13.54 |
High: | $13.75 |
Low: | $13.47 |
Volume: | 191,089 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | Alvotech (NASDAQ:ALVO)
The confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi ® and Simponi Aria ® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid arthritis Alvotech is the first company to publicly announce positiv...
2024-04-19 13:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Alvotech (NASDAQ:ALVO)
Subject | By | Source | When |
---|---|---|---|
$ALVO MomentumIts trading | Liquid_Bull | investorshub | 06/06/2023 9:46:04 AM |
Alvotech Provides Regulatory Update on AVT02 Biologics License Application | Liquid_Bull | investorshub | 04/14/2023 1:08:16 AM |
Just to be clear the company name is | Liquid_Bull | investorshub | 03/20/2023 3:44:42 PM |
Alvotech | Liquid_Bull | investorshub | 02/26/2023 2:33:24 AM |
News, Short Squeeze, Breakout and More Instantly...
Alvotech Company Name:
ALVO Stock Symbol:
NASDAQ Market:
The confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi ® and Simponi Aria ® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid arthritis Alvotech is the first company to publicly announce positiv...
U.S. stocks were mixed, with the Nasdaq Composite falling over 100 points on Friday. Shares of Fifth Third Bancorp (NASDAQ:FITB) rose during Friday...
2024-04-19 13:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...